Palo Alto, CA-based Provect AI has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its software platform that generates 3D intraoperative images from standard C-arm x-ray systems.
The software reconstructs volumetric 3D images from 2D C-arm x-ray data without requiring a CT scanner, additional imaging hardware, or changes to existing surgical workflow, according to the company. It is intended for spine and orthopedic image-guided procedures and exports images in DICOM format for use with hospital PACS and third-party navigation systems.
Alongside the clearance, Provect AI has raised $7 million to support commercial expansion, customer deployments, and continued product development. The round was led by Arteria Capital and ValueStream Ventures, with participation from Newfund Capital and Sand Hill Angels, the firm noted.
